From the Journals

Could tackling maternal obesity prevent later CVD in offspring?


 

FROM ATHEROSCLEROSIS


“Raised leptin levels, secreted by the adipose tissue, inhibit the in vitro proliferation of smooth muscle cells and could impede the angiogenesis process in vivo, but this assumption needs scientific validation in humans,” they said in their review.

However, human studies are lacking, aside from the epidemiologic reports that “cannot be used to confirm or contradict” the fetal programming hypothesis, they said.

Meanwhile, an increasing body of evidence has suggested that stressors in critical periods of fetal development may lead to epigenetic alterations that could play a role in either up-regulating atherogenic genes or down-regulating enzymatic activities that guard against oxidative stress.

For example, cohort studies have shown differences in DNA methylation among offspring born before and after bariatric surgery in the mother, which has lent credence to the hypothesis that maternal obesity in pregnancy alters methylation patterns for those offspring, Ms. Van De Maele and her colleagues wrote.

Lifestyle changes in obese pregnant women may have an effect on adverse metabolic or cardiovascular outcomes in offspring, although results to date are inconclusive, they added.

Diet, exercise, or both during pregnancy may lower the risk of macrosomia, respiratory distress syndrome, or other neonatal outcomes, particularly in high-risk women, according to the conclusions of a 2015 Cochrane review that Ms. Van De Maele and her coauthors cited.

However, follow-up studies on offspring are scarce and have shown no clear effects on long-term metabolic profiles in offspring, likely because of insufficient follow-up time, they said in their review.

Ms. Van De Maele and her coauthors said they had no conflict of interest disclosures related to their manuscript.

SOURCE: Van De Maele K et al. Atherosclerosis. 2018 Jun. doi: 10.1016/j.atherosclerosis.2018.06.016.

Pages

Recommended Reading

The FDA’s novel drugs approved in 2017
MDedge Family Medicine
GDM, subsequent diabetes predictive of later renal damage
MDedge Family Medicine
How more midwives may mean healthier mothers
MDedge Family Medicine
Pregnancy may be ideal time to consider switching MS drugs
MDedge Family Medicine
Mifepristone, then misoprostol is best in early pregnancy loss
MDedge Family Medicine
No link found between fluconazole use and neonatal death risk
MDedge Family Medicine
NIH launches HEAL Initiative to combat opioid crisis
MDedge Family Medicine
Thyroid markers linked to risk of gestational diabetes
MDedge Family Medicine
Novel blood test that predicts gestational age, fetal development, could improve prenatal care
MDedge Family Medicine
Maternal use of pot and tobacco may boost birth defect risk
MDedge Family Medicine